4.290USD-3.60%Mkt Cap: 222.76M USDP/E: —Last update: 2026-06-01
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap222.76M USD
Enterprise Value130.87M USD
Revenue (TTM)3.93M USD
Gross Profit-34.27M USD
Net Income (TTM)-80.40M USD
Revenue/Share0.0990 USD
Last Price4.290 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees48
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.00
PEG—
EV/EBITDA-2.60
EV/Revenue33.27
P/S57.94
P/B7.38
EPS (TTM)-2.35
EPS (Forward)-0.73
52W Range
1.30546% of range7.750
52W High7.750 USD
52W Low1.305 USD
Profitability
Gross Margin0.00%
Oper. Margin-1010.12%
EBITDA Margin0.00%
Profit Margin-2298.54%
ROE-168.55%
ROA-68.25%
Growth
Revenue Growth50.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-29.55M USD
CapEx (TTM)279.00K USD
FCF Margin-366.45%
FCF Yield-6.47%
Net Debt-97.09M USD
Net Debt/EBITDA1.93
Balance Sheet
Debt/Equity0.04
Current Ratio6.15
Quick Ratio5.97
Book Value/Sh0.5950 USD
Cash/Share1.911 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)8.200 USD
Target Range5.000 USD – 12.00 USD
# Analysts5
Ownership
Shares Out.51.93M
Float29.22M
Insiders13.07%
Institutions86.62%
Short Interest
Short Ratio3.8d
Short % Float0.92%
Short % Out.0.62%
Shares Short322.40K
Short (prev mo.)468.37K
Technical
SMA 504.447 (-3.5%)
SMA 2004.053 (+5.8%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)68.08K
Avg Vol (10d)60.17K
Technical Indicators
RSI (14)51.3
MACD0.0031
MACD Signal-0.0196
MACD Hist.+0.0226
BB Upper4.746 USD
BB Middle4.323 USD
BB Lower3.900 USD
BB Width19.57%
ATR (14)0.4067 USD
Vol Ratio (20d)0.46x